Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.
Saved in:
| Title: | Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. |
|---|---|
| Authors: | Li C; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Yu D; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Wu X; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Liang H; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Zhou Z; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Xie Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Li T; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Wu J; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China., Lu F; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Feng L; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Mao M; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Lin L; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Guo H; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Yue S; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Wang F; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Peng Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Hu Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Wang Z; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China., Yu J; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Zhang Y; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Lu J; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China., Ning H; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Yang H; China National Biotec Group Company Limited, Beijing, China., Fu D; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., He Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Zhou D; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Du T; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Duan K; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China., Dong D; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Deng K; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Zou X; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Zhang Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Zhou R; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Gao Y; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Zhang X; Research Laboratory of Clinical Virology, Ruijin Hospital and Ruijin Hospital North, National Research Center for Translational Medicine, Shanghai Jiao Tong University of Medicine, Shanghai, China. zhangx@shsmu.edu.cn., Yang X; China National Biotec Group Company Limited, Beijing, China. yangxiaoming@sinopharm.com. |
| Source: | Nature communications [Nat Commun] 2021 Aug 05; Vol. 12 (1), pp. 4846. Date of Electronic Publication: 2021 Aug 05. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34354086 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Yu+D%22">Yu D</searchLink>; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wu+X%22">Wu X</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Liang+H%22">Liang H</searchLink>; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhou+Z%22">Zhou Z</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Xie+Y%22">Xie Y</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Li+T%22">Li T</searchLink>; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Lu+F%22">Lu F</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Feng+L%22">Feng L</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Mao+M%22">Mao M</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Lin+L%22">Lin L</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Guo+H%22">Guo H</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Yue+S%22">Yue S</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Peng+Y%22">Peng Y</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Hu+Y%22">Hu Y</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Yu+J%22">Yu J</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Ning+H%22">Ning H</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Yang+H%22">Yang H</searchLink>; China National Biotec Group Company Limited, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Fu+D%22">Fu D</searchLink>; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhou+D%22">Zhou D</searchLink>; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Du+T%22">Du T</searchLink>; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Duan+K%22">Duan K</searchLink>; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Dong+D%22">Dong D</searchLink>; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Deng+K%22">Deng K</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Zou+X%22">Zou X</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Zhou+R%22">Zhou R</searchLink>; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Gao+Y%22">Gao Y</searchLink>; Beijing Tiantan Biological Products Co., Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Research Laboratory of Clinical Virology, Ruijin Hospital and Ruijin Hospital North, National Research Center for Translational Medicine, Shanghai Jiao Tong University of Medicine, Shanghai, China. zhangx@shsmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Yang+X%22">Yang X</searchLink>; China National Biotec Group Company Limited, Beijing, China. yangxiaoming@sinopharm.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 Aug 05; Vol. 12 (1), pp. 4846. <i>Date of Electronic Publication: </i>2021 Aug 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34354086 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-021-25109-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4846 Titles: – TitleFull: Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li C – PersonEntity: Name: NameFull: Yu D – PersonEntity: Name: NameFull: Wu X – PersonEntity: Name: NameFull: Liang H – PersonEntity: Name: NameFull: Zhou Z – PersonEntity: Name: NameFull: Xie Y – PersonEntity: Name: NameFull: Li T – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Lu F – PersonEntity: Name: NameFull: Feng L – PersonEntity: Name: NameFull: Mao M – PersonEntity: Name: NameFull: Lin L – PersonEntity: Name: NameFull: Guo H – PersonEntity: Name: NameFull: Yue S – PersonEntity: Name: NameFull: Wang F – PersonEntity: Name: NameFull: Peng Y – PersonEntity: Name: NameFull: Hu Y – PersonEntity: Name: NameFull: Wang Z – PersonEntity: Name: NameFull: Yu J – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Lu J – PersonEntity: Name: NameFull: Ning H – PersonEntity: Name: NameFull: Yang H – PersonEntity: Name: NameFull: Fu D – PersonEntity: Name: NameFull: He Y – PersonEntity: Name: NameFull: Zhou D – PersonEntity: Name: NameFull: Du T – PersonEntity: Name: NameFull: Duan K – PersonEntity: Name: NameFull: Dong D – PersonEntity: Name: NameFull: Deng K – PersonEntity: Name: NameFull: Zou X – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Zhou R – PersonEntity: Name: NameFull: Gao Y – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Yang X IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 08 Text: 2021 Aug 05 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |